Magnesium
Nuts and seeds, Legumes, Whole grains, Leafy green vegetables.
Tag
Migraine and headache references connect nutrients and bioactives that are commonly studied for migraine prevention, headache triggers, or nervous-system support. This is a navigation page, not a migraine treatment plan.
| Item | Type | Relationship | Evidence |
|---|---|---|---|
| Magnesium | nutrient | May Support | NCCIH describes magnesium migraine evidence as limited; official magnesium sources remain the base for deficiency, forms, and safety. Traditional / Safety Reference |
| Riboflavin (B2) | nutrient | May Support | NCCIH and ODS describe riboflavin as a studied migraine prevention topic with generally cautious wording. Traditional / Safety Reference |
| CoQ10 | bioactive | May Support | NCCIH describes CoQ10 migraine evidence as limited and outcome-specific. Traditional / Safety Reference |
| Omega-3 Fish Oil | bioactive | Caution / Limited Evidence | NCCIH separates diet-pattern context from omega-3 supplement evidence; high-dose omega-3s also need bleeding-risk review. Traditional / Safety Reference |
| Caffeine | bioactive | Possible Side Effect | FDA caffeine safety context plus NINDS migraine trigger and lifestyle framing. Government Health Agency |
Nuts and seeds, Legumes, Whole grains, Leafy green vegetables.
Dairy foods, Eggs, Meat, Fortified grains.
Organ meats, beef, sardines, mackerel, peanuts.
Salmon, sardines, mackerel, herring, anchovies.
Coffee, tea, yerba mate, guarana, cacao.
Magnesium is commonly discussed in migraine prevention contexts, but evidence and appropriate dose depend on the person and supplement form. | The DRI UL applies to supplemental/pharmacological magnesium, not magnesium naturally present in food and water.
Omega-3-rich diets may be discussed in migraine contexts, but omega-3 supplements have not clearly reduced migraine frequency or severity in NCCIH framing. | blood thinners | bleeding risk | surgery
Caffeine can acutely affect headache for some people but can also contribute to sleep disruption, withdrawal headache, anxiety, or individual migraine triggers. | pregnancy/breastfeeding | sleep | anxiety
These are the dated references used for this tag. Live research searches can change; these links explain the fixed wording shown on this page.
National Center for Complementary and Integrative Health | Acquired 2026-08-03 | Traditional / Safety Reference
Migraine complementary health framing, Magnesium migraine evidence limitations, Riboflavin migraine context.
NIH Office of Dietary Supplements | Acquired 2026-07-23 | Official Reference
Magnesium supplement forms, Magnesium bioavailability, Magnesium medication interactions.
NIH Office of Dietary Supplements | Acquired 2026-08-03 | Official Reference
Riboflavin migraine prevention context, Clinician-guided riboflavin supplement use, Migraine evidence limitations.
NIH Office of Dietary Supplements | Acquired 2026-07-24 | Official Reference
Riboflavin deficiency signs, Skin disorders, Mouth and lip changes.
NIH Office of Dietary Supplements | Acquired 2026-07-23 | Official Reference
ALA AI, EPA/DHA no official DRI, Fish, krill, algal, and plant omega sources.
U.S. Food and Drug Administration | Acquired 2026-07-23 | Government Health Agency
Caffeine safety-limit context.
National Institute of Neurological Disorders and Stroke | Acquired 2026-08-03 | Academic Review
Migraine medical context, Migraine preventive treatment context, Non-drug approach framing.
Magnesium is commonly discussed in migraine prevention contexts, but evidence and appropriate dose depend on the person and supplement form.
Evidence note: NCCIH describes magnesium migraine evidence as limited; official magnesium sources remain the base for deficiency, forms, and safety.
Sources: Headaches and Complementary Health Approaches (2026-08-03)Traditional / Safety Reference, Magnesium Fact Sheet for Health Professionals (2026-07-23)Official Reference
Riboflavin is studied for migraine prevention and is discussed by NIH ODS as a clinician-guided option, while routine intake needs remain separate from high-dose migraine study contexts.
Evidence note: NCCIH and ODS describe riboflavin as a studied migraine prevention topic with generally cautious wording.
Sources: Headaches and Complementary Health Approaches (2026-08-03)Traditional / Safety Reference, ODS Frequently Asked Questions: Riboflavin and Migraine (2026-08-03)Official Reference, Riboflavin Fact Sheet for Health Professionals (2026-07-24)Official Reference
CoQ10 has limited evidence for reducing migraine duration or frequency in some studies, but it is not a general headache treatment claim.
Evidence note: NCCIH describes CoQ10 migraine evidence as limited and outcome-specific.
Sources: Headaches and Complementary Health Approaches (2026-08-03)Traditional / Safety Reference
Caffeine can acutely affect headache for some people but can also contribute to sleep disruption, withdrawal headache, anxiety, or individual migraine triggers.
Evidence note: FDA caffeine safety context plus NINDS migraine trigger and lifestyle framing.
Sources: Spilling the Beans: How Much Caffeine is Too Much? (2026-07-23)Government Health Agency, Migraine (2026-08-03)Academic Review
Omega-3-rich diets may be discussed in migraine contexts, but omega-3 supplements have not clearly reduced migraine frequency or severity in NCCIH framing.
Evidence note: NCCIH separates diet-pattern context from omega-3 supplement evidence; high-dose omega-3s also need bleeding-risk review.
Sources: Headaches and Complementary Health Approaches (2026-08-03)Traditional / Safety Reference, Omega-3 Fatty Acids Fact Sheet for Health Professionals (2026-07-23)Official Reference